BMY vs LQDA · P/E 17, rev $24.46B vs rev $304.5M
Bristol-Myers Squibb Company (BMY) versus Liquidia Technologies Inc (LQDA) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Liquidia Technologies Inc (LQDA) is a biotechnology company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported LQDA revenue for 2026-06-30 was $304.5M. Net income was $127.6M. LQDA currently screens at market cap $1.04B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. LQDA currently screens at market cap $1.04B.
Not investment advice. Open the BMY and LQDA stock pages for the full models.
Not investment advice.